Cizzle Biotechnology Holdings PLC
CIZ
ISIN GB00BNG2VN02 / Valor 111334752
Cizzle Biotechnology Holdings PLC
UMushroom community rating:
About company
Cizzle Biotechnology Holdings PLC is a biotechnology company focused on the development of early-stage cancer diagnostics. Initially funded by Yorkshire Cancer Research, White Rose Technology Seed Corn Fund, Finance Yorkshire Seedcorn LLP, and Viking Members, the company has developed a laboratory test that utilizes the CIZ1 B biomarker to detect lung cancer. This test has undergone validation and has a proof-of-concept prototype that is designed for potential use in hospital laboratory settings. Cizzle Biotech aims to advance its diagnostic technology to improve early detection and treatment outcomes for lung cancer patients.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
14 M
Market cap (USD)
4,090,813
Daily traded volume (Shares)
0.018 / 0.018
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
